This HTML5 document contains 188 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n15http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n3http://linked.opendata.cz/ontology/sukl/
n6http://linked.opendata.cz/resource/sukl/specialization-restriction/
skoshttp://www.w3.org/2004/02/skos/core#
n21http://linked.opendata.cz/resource/sukl/indgroup/
n13http://linked.opendata.cz/resource/sukl/packing/
n7http://linked.opendata.cz/resource/sukl/company/
n16http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000739/
n9http://linked.opendata.cz/resource/sukl/active-ingredient/
n11http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029017/price-of-originator/
n18http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/resource/sukl/registration-state/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029017/reimbursement/
n10http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029017/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029017/core-reimbursement/
n17http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0029017/price/
n20http://linked.opendata.cz/resource/atc/
n12http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item
n2:0029017
rdf:type
n3:MedicinalProductPackaging
dcterms:title
MIRCERA 100 MIKROGRAMŮ/0,3 ML
skos:notation
0029017
n3:hasATCCode
n20:B03XA03
n3:hasActiveIngredient
n9:PEGEPOETINUM-BETA
n3:hasDefinedDailyDose
n10:ddd
n3:hasDosageForm
n12:INJ-SOL-SDR-IVN
n3:hasPackagingSize
1X0.3ML
n3:hasPacking
n13:ISP
n3:hasRegistrationHolder
n7:RRGGB
n3:hasRegistrationState
n5:R
n3:hasRouteOfAdministration
n15:SDR-IVN
n3:hasStrength
333RG/ML
n3:hasIndicationGroup
n21:12
n3:hasSpecializationRestriction
n6:INT n6:HEM n6:NEF n18:blank-cell
n3:containsDefinedDailyDoses
25.0
n3:hasRegistrationCode
EU/1/07/400/010
n3:hasTitleSupplement
SDR+IVN INJ SOL 1X0.3ML
n3:containsUsualTherapeuticalDailyDoses
25
n3:hasBreakMarketingDate
2012-01-01+01:00
n3:hasCoreReimbursementSpecification
n8:2013-04-01 n8:2013-05-01 n8:2013-02-01 n8:2013-03-01 n8:2013-01-01 n8:2013-01-05 n8:2013-11-01 n8:2013-12-01 n8:2013-09-01 n8:2013-10-01 n8:2013-08-01 n8:2013-08-03 n8:2013-06-01 n8:2013-07-01 n8:2014-06-13 n8:2014-07-01 n8:2014-05-01 n8:2014-06-01 n8:2014-03-01 n8:2014-04-01 n8:2014-01-01 n8:2014-02-01 n8:2014-11-19 n8:2014-12-01 n8:2014-10-02 n8:2014-11-01 n8:2014-09-01 n8:2014-10-01 n8:2014-07-03 n8:2014-08-01 n8:2015-05-01 n8:2015-06-01 n8:2015-04-01 n8:2015-04-02 n8:2015-02-01 n8:2015-03-01 n8:2015-01-01 n8:2015-01-13 n8:2015-07-01 n8:2015-07-02
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n11:2014-03-01 n11:2014-04-01 n11:2014-01-01 n11:2014-02-01 n11:2014-06-13 n11:2014-07-01 n11:2014-05-01 n11:2014-06-01 n11:2013-08-01 n11:2013-08-03 n11:2013-06-01 n11:2013-07-01 n11:2013-11-01 n11:2013-12-01 n11:2013-09-01 n11:2013-10-01 n11:2013-01-01 n11:2013-01-05 n11:2013-04-01 n11:2013-05-01 n11:2013-02-01 n11:2013-03-01 n11:2015-07-01 n11:2015-07-02 n11:2015-02-01 n11:2015-03-01 n11:2015-01-01 n11:2015-01-13 n11:2015-05-01 n11:2015-06-01 n11:2015-04-01 n11:2015-04-02 n11:2014-09-01 n11:2014-10-01 n11:2014-07-03 n11:2014-08-01 n11:2014-11-19 n11:2014-12-01 n11:2014-10-02 n11:2014-11-01
n3:hasPriceSpecification
n17:2015-07-01 n17:2015-07-02 n17:2015-04-01 n17:2015-04-02 n17:2015-05-01 n17:2015-06-01 n17:2015-01-01 n17:2015-01-13 n17:2015-02-01 n17:2015-03-01 n17:2014-10-02 n17:2014-11-01 n17:2014-11-19 n17:2014-12-01 n17:2014-07-03 n17:2014-08-01 n17:2014-09-01 n17:2014-10-01 n17:2014-05-01 n17:2014-06-01 n17:2014-06-13 n17:2014-07-01 n17:2014-01-01 n17:2014-02-01 n17:2014-03-01 n17:2014-04-01 n17:2013-09-01 n17:2013-10-01 n17:2013-11-01 n17:2013-12-01 n17:2013-06-01 n17:2013-07-01 n17:2013-08-01 n17:2013-08-03 n17:2013-02-01 n17:2013-03-01 n17:2013-04-01 n17:2013-05-01 n17:2013-01-01 n17:2013-01-05
n3:hasReimbursementSpecification
n4:2015-07-01 n4:2015-07-02 n4:2015-05-01 n4:2015-06-01 n4:2015-04-01 n4:2015-04-02 n4:2015-02-01 n4:2015-03-01 n4:2015-01-01 n4:2015-01-13 n4:2014-11-19 n4:2014-12-01 n4:2014-10-02 n4:2014-11-01 n4:2014-09-01 n4:2014-10-01 n4:2014-07-03 n4:2014-08-01 n4:2014-06-13 n4:2014-07-01 n4:2014-05-01 n4:2014-06-01 n4:2014-03-01 n4:2014-04-01 n4:2014-01-01 n4:2014-02-01 n4:2013-11-01 n4:2013-12-01 n4:2013-09-01 n4:2013-10-01 n4:2013-08-01 n4:2013-08-03 n4:2013-06-01 n4:2013-07-01 n4:2013-04-01 n4:2013-05-01 n4:2013-02-01 n4:2013-03-01 n4:2013-01-01 n4:2013-01-05
n3:hasResumedMarketingDate
2012-10-08+02:00
n3:hasUsualTherapeuticalDailyDose
n10:utdd
n3:spcFile
http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F000739%2FWC500033672.pdf
n3:spcUri
n16:WC500033672.pdf